Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Adding menthol to topical creams for osteoarthritis provides significant pain relief

19.04.2004


Study demonstrates improved mobility, less pain, in patients with osteoarthritis



Osteoarthritis (OA) is a progressive, degenerative joint disease estimated to affect more than 21 million individuals in the United States. The Arthritis Foundation reports that arthritis is the leading disability of Americans resulting in over 39 million medical visits per year and $65 billion in medical expenses and lost wages. This condition is characterized by erosion of articular cartilage, caused by enzymatic and mechanical breakdown of the extracellular matrix. The most common symptoms are pain, stiffness, reduced joint range of motion, and limitations to normal activities of daily living such as getting up from a chair, walking, balance and strength, and ascending/descending stairs, as well as limitations to local muscular endurance and hand grip strength in patients with OA of the upper extremities.

Pain reducing medications such as acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), and COX-2 inhibitors have been common treatments for osteoarthritis in the growing elderly population. However, these medications often have painful side effects or do not react well with other medications. Accordingly, there is a need for alternative treatments for the osteoarthritis patient.


One proven alternative treatment is the use of oral and/or a topical blend of cetylated fatty acids. Cetylated monounsaturated fatty acids have been shown to provide protection against arthritis in rats; a recent study demonstrated that a topical cream consisting of a blend of cetylated fatty acids significantly reduced pain and improved physical function in patients with knee osteoarthritis. In that study, the first treatment of the topical cream caused acute improvements in stair climbing ability, timed "up and go" performance, knee range of motion, and a reduction in pain within 30 minutes. Additional improvements were observed after 30 days of treatment. However, this research was for the topical cream in its developmental stage and was only used with patients with knee osteoarthritis.

A New Study

Recently, menthol has been added to this topical cream. Menthol has been shown to possess analgesic properties thereby reducing the sensation of pain. A new study extends previous research and examines the effects of a topical cream consisting of cetylated fatty acids, along with the addition of menthol, on pain and functional performance in patients with knee osteoarthritis over the course of one week. Additionally, several patients with elbow and wrist osteoarthritis were included to examine potential effects on upper-extremity performance and pain in these individuals.

The authors of "Treatment With A Cetylated Fatty Acid Topical Cream With Menthol Reduces Pain and Improves Functional Performance In Patients With Osteoarthritis," are Nicholas A. Ratamess, William J. Kraemer, Jeffrey A. Anderson, David P. Tiberio, Michael E. Joyce, Barry N. Messinger, Jeff S. Volek, Duncan N. French, Matthew J. Sharman, Ana L. Gómez, Barry A. Spiering, Jason D. Vescovi, Ricardo Silvestre, Carl M. Maresh, and Robert L. Hesslink Jr. The participating institutions were the Human Performance Laboratory, University of Connecticut, Storrs, CT; Department of Health and Exercise Science, The College of New Jersey, Ewing, NJ; and Imagenetix, Inc., San Diego, CA. The researchers will present their findings at the American Physiological Society’s (APS) (www.the-aps.org) annual scientific conference, Experimental Biology 2003, being held April 17-21, 2004, at the Washington, D.C. Convention Center.

Methodology

Twenty-eight patients (10 with knee OA, 10 with wrist OA, 8 with elbow OA) were assigned to an experimental group based upon the location of his/her diagnosed osteoarthritis (i.e., knee, elbow, or wrist). Each patient applied the cream to the affected area twice per day every day for one week and subsequently returned to the lab for post-study functional performance testing. Subjects were tested for pain, stiffness, knee range of motion (ROM), balance, and ability to rise from a chair, walk, and ascend/descend stairs for patients with knee osteoarthritis; patients with elbow and wrist osteoarthritis were tested for measures of grip strength, elbow ROM, muscular strength, local muscular endurance, and pain.

The significant improvements observed in the research team’s previous investigation with use of a topical cream consisting of a blend of cetylated fatty acids, coupled and the high test-retest reliability (R = 0.95 to 0.99), precluded the need for a control group for this study.

Results

Fifteen test results were obtained for patients with osteoarthritis of the knee, twelve for patients having OA in the elbow, and eight measurements were taken with patients diagnosed with wrist osteoarthritis. Across the board, the test measurements (available upon request) revealed that use of a cetylated fatty acid topical cream with the addition of menthol produced significant improvements in physical performance and reduced pain in patients with OA of the knee, wrist, and elbow.

Conclusions

Topical creams containing cetylated fatty acid are now being sold to consumers for the knee osteoarthritis. This study demonstrates that the addition of menthol adds a new pain relief component to the treatment and its effectiveness for osteoarthritis of the knee, elbow and wrist.


The American Physiological Society (APS) is America’s oldest biomedical sciences research society. The not-for-profit society, with some 11,000 members, is the publisher of 14 scientific journals, including the American Journal of Physiology, which has been published since 1898.

Donna Krupa | EurekAlert!
Further information:
http://www.the-aps.org/

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>